Stockreport

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]

Vivani Medical, Inc.  (VANI) 
PDF implant advance NPM-139, miniature, ultra long-acting semaglutide implant under development for chronic weight management toward a Phase 1 clinical study with results an [Read more]